ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, a Novel Methylated ctDNA Therapy Response Monitoring Assay in Patients With Advanced GI Cancer Undergoing Active Treatment"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, a Novel Methylated ctDNA Therapy Response Monitoring Assay in Patients With Advanced GI Cancer Undergoing Active Treatment"

By Insights from 2024 ASCO® GI Annual Meeting FEATURING Ilyas Sahin

64 views

February 5, 2024

Comments 0

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Inaugural Houston Methodist Neal Cancer Center GI Oncology Symposium

Fri, Dec 6, 2024

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

2.5K views

7 months ago

Early-Onset CRC: A New Epidemic With Knowns and Unknowns

Ibrahim Sahin

2.1K views

8 months ago

Young Onset Colorectal Cancer: A New Epidemic?

Ibrahim Sahin

6.3K views

1 year ago

DDW 2024 Highlights: Pancreatic Cancer Screening in High Risk Indivi…

DDW 2024 Conference Coverage

T. Kachaamy

624 views

4 months ago

Helicobacter Pylori: A Bacterium That Causes Gastric Cancer

Vanderbilt University Medical Center (VUMC)

R. Peek

1.1K views

10 months ago

Screening for Pancreatic Cancer

Montefiore Einstein

A. L. Lucas

1.7K views

1 year ago

Colon Polyp with Carcinoma In-Situ, Intramucosal Cancer or Invasive …

Florida Gastroenterologic Society

D. Yang

1.3K views

1 year ago

Risk Stratification and Screening for Early Onset Colorectal Cancer

Fight Colorectal Cancer

J. Demb, F. May, A. Zauber, I. Lansdorp-Vogelaar, A. Shaukat, J. Perea Garcia, H. Hampel

519 views

2 months ago

The Evolving Role of Liquid Biopsy With a Focus on NSCLC, BC, and CRC

COR2ED The Heart of Medical Education

U. Malapelle

262 views

1 month ago

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Integrity CE

V. Lee, R. Kumar, N. Bhagat, E. Winslow

369 views

7 months ago

The Rising Tide of CRC in Younger Adults: Why Is This Happening & Wh…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

C. Eng

494 views

6 months ago

Anal Cancer: Risk Factors and Prevention

GRACE

P. Romesser

298 views

2 months ago

New

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

184 views

3 weeks ago

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Integrity CE

V. Lee, E. Christenson, N. Bhagat, E. Winslow

252 views

7 months ago

Pancreas Cancer: Update and Review

Scripps Health

W. Coyle

270 views

3 months ago

Overview of Esophageal & Gastric Cancer Diagnosis & Staging

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Shankaran

204 views

4 months ago

Current Status for the Early Detection of Pancreatic Cancer

Philadelphia County Medical Society

R. Brand

2.1K views

1 year ago

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

326 views

6 months ago

ESMO 2024 Summary: Liquid Biopsies in GI Cancers - Learnings From Co…

2024 ESMO Annual Meeting Insights Hub

N. Starling

175 views

1 month ago

Prevention of Esophageal Cancer: Screening and Surveillance

Dana-Farber Cancer Institute

K. Jajoo

351 views

6 months ago

AUTOPLAY

Login

Login

Join VuMedi

ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, a Novel Methylated ctDNA Therapy Response Monitoring Assay in Patients With Advanced GI Cancer Undergoing Active Treatment"

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Recommended

Inaugural Houston Methodist Neal Cancer Center GI Oncology Symposium

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

Early-Onset CRC: A New Epidemic With Knowns and Unknowns

Young Onset Colorectal Cancer: A New Epidemic?

DDW 2024 Highlights: Pancreatic Cancer Screening in High Risk Indivi…

Helicobacter Pylori: A Bacterium That Causes Gastric Cancer

Screening for Pancreatic Cancer

Colon Polyp with Carcinoma In-Situ, Intramucosal Cancer or Invasive …

Risk Stratification and Screening for Early Onset Colorectal Cancer

The Evolving Role of Liquid Biopsy With a Focus on NSCLC, BC, and CRC

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

The Rising Tide of CRC in Younger Adults: Why Is This Happening & Wh…

Anal Cancer: Risk Factors and Prevention

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Pancreas Cancer: Update and Review

Overview of Esophageal & Gastric Cancer Diagnosis & Staging

Current Status for the Early Detection of Pancreatic Cancer

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

ESMO 2024 Summary: Liquid Biopsies in GI Cancers - Learnings From Co…

Prevention of Esophageal Cancer: Screening and Surveillance